Related Experiment Videos
Differences in prognosis for boys and girls with acute lymphoblastic leukaemia
Insights
Outcomes for children with acute lymphoblastic leukemia (ALL) differed by sex after central nervous system (CNS) prophylaxis was introduced. Female patients showed better outcomes, suggesting sex influences treatment duration and CNS prophylaxis effectiveness.
Area of Science:
- Pediatric Oncology
- Hematology
- Clinical Trials
Background:
- Acute lymphoblastic leukemia (ALL) is the most common childhood cancer.
- Treatment protocols have evolved significantly over decades, impacting patient outcomes.
- Central nervous system (CNS) involvement is a critical factor in ALL treatment and prognosis.
Purpose of the Study:
- To analyze the impact of central nervous system (CNS) prophylaxis on treatment outcomes in pediatric acute lymphoblastic leukemia (ALL).
- To investigate potential sex-based differences in ALL treatment response and long-term prognosis.
- To evaluate the influence of treatment duration on outcomes in relation to patient sex.
Main Methods:
- Retrospective analysis of 3161 children enrolled in six Childrens Cancer Study Group (CCSG) ALL studies (1968-1978).
- Comparison of outcomes between studies with and without CNS prophylaxis (radiation).
- Analysis of treatment duration (3 vs. 5 years) in a subset of patients.
- Stratification of results by patient sex.
Main Results:
- Early studies without CNS prophylaxis showed similar outcomes for males and females.
- Studies incorporating CNS radiation prophylaxis revealed a consistent outcome advantage for females.
- The observed sex difference emerged 6-12 months post-remission and was exacerbated by therapy withdrawal.
- Randomized trials on treatment duration suggested sex-specific implications for maintenance therapy.
Conclusions:
- Central nervous system (CNS) prophylaxis strategies in pediatric ALL appear to have differential effects based on patient sex.
- Sex is a significant factor influencing treatment duration and the optimal approach to CNS prophylaxis in ALL.
- Further research is warranted to elucidate the biological and clinical mechanisms underlying sex-based differences in ALL outcomes.
Abstract:
In the period 1968--78, 3161 children were enrolled in six studies of acute lymphoblastic leukaemia by participating institutions of the Childrens Cancer Study Group. In the first two studies, which did not include central-nervous-system (CNS) prophylaxis in the treatment programme, the outcome for male and female patients was very similar. In the following four studies, which included radiation prophylaxis to the CNS, a difference in outcome favouring females appeared consistently. This difference began about 6--12 months after initial remission and was further accentuated by withdrawal of therapy. Some of these studies also included a randomised trial of duration of therapy, studying 3 versus 5 years of maintenance treatment. Analysis of these studies suggests that sex group has implications both for duration of treatment and for optimum central-nervous-system prophylaxis.